Drug Action Increased Completed Phase 2 Trials for Poloxamer 188 (DB11333)

IndicationStatusPhase
DBCOND0051995 (Drug Action Increased)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03001466A Randomized Controlled Trial Comparing Urea Loaded Nanoparticles to Placebo: a New Concept for Cataract ManagementHealth Services Research